FDA approves diabetes drug Victoza but orders safety studies

01/25/2010 | Wall Street Journal, The

The FDA approved Victoza, a Type 2 diabetes drug from Novo Nordisk, with an order that the Danish firm conduct additional safety studies of the product. The studies would focus on a possible association between Victoza, or liraglutide, and a heightened risk of medullary thyroid cancer and other related diseases.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Systems Test - V&V Engineer - 14000008LS
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
Multiple Locations, SL_Multiple Locations
Director, Antibiotics and Innovation Project
The Pew Charitable Trusts
Washington, DC